Summary: Somatic internal tandem duplications (ITDs) are known to play important roles in cancer pathogenesis. Although recent advances in high-throughput sequencing technologies have enabled genome-wide detection of various types of genomic mutations, including single nucleotide variants, indels and structural variations, only a few studies have focused on ITDs. We have developed an analytical tool called 'Genomon ITDetector' for genome-wide detection of somatic ITDs. After evaluating the sensitivity and precision of the proposed approach using synthetic data, we have demonstrated that it can successfully detect not only common ITDs involving FLT3, but also a number of ITDs affecting other putative driver genes in acute myeloid leukemia exome sequencing data.
INTRODUCTION
Recent advances in high-throughput sequencing technologies have enabled genome-wide detection of various genomic alterations in cancer cells, and a number of analytical tools have been developed for detecting single nucleotide variants, short indels (Shiraishi et al., 2013) and structural variations (SVs) from cancer genome sequencing data. On the other hand, it is widely known that an internal tandem duplication (ITD) that involves several tens to several hundreds of nucleotides represents a common type of somatic alteration that plays an important role in cancer pathogenesis through either activating or inactivating affected genes. In particular, ITDs involving FMS-like tyrosine kinase 3 (FLT3) are among the most frequent genetic lesions, and are found in 30% of patients with acute myeloid leukemia (AML), leading to aberrant activation of the kinase and negatively affecting survival (Kindler et al., 2010) . However, despite their potential importance in cancer development, somatic ITDs have been poorly focused because most current approaches are not sensitive enough to identify indels of more than several tens of base pairs or SVs within small-scale regions (51000 bp), rendering ITDs as 'blind spots' for most existing analytical methods. In this article, we present a novel software application, Genomon ITDetector, which is specifically designed for performing sensitive and genome-wide detection of somatic ITDs spanning several tens to several hundreds of base pairs from cancer genome sequencing data.
METHODS
When short reads at the positions of ITDs are aligned using tools such as BWA (Li and Durbin, 2009) , which support partial alignment, they show characteristic patterns: soft-clipped sequences (i.e. an unmatched fragment in a partially mapped read, see Fig. 1a ) are observed outside the breakpoint pairs, corresponding to the sequences inside the breakpoint pairs (which we call ITD breakpoint pairs, ITD-BPPs, see Fig. 1b ). The basic strategy for detecting somatic ITDs using Genomon ITDetector is to initially perform genome-wide identification of ITD-BPPs in the target tumor sample, and then filter out uncertain candidates to remove false positives because of the mis-alignments caused by redundancy of the genome, relying on multiple non-matched control samples ( Supplementary Fig. S1 ). Briefly, the procedure adopted in Genomon ITDetector after sequencing alignment is as follows (see Supplementary Materials for details):
(1) All the soft-clipped reads satisfying the conditions in Supplementary Materials S.1 in the target tumor sample are remapped to the human reference genome (see Fig. 1b ), and ITD-BPPs are identified (see also Supplementary Fig. S2 ).
(2) Support reads and their mate pairs for each ITD-BPP are assembled to generate a contig sequence. Then, the contig sequence is checked to determine whether it truly contains the sequence being inside the corresponding ITD-BPP [which we call presumed duplicated nucleotides (PDN)]. For this purpose, alignment of the contig sequence to the reference genome sequence around the corresponding ITD-BPP is performed to extract the excess unaligned part [which we call observed inserted nucleotides (OIN)], and the OIN is compared with the PDN of the corresponding ITD-BPP by pairwise alignment. Based on these results, we assign a degree of confidence to each ITD as follows (see Supplementary Not applicable: Candidates that do not fall into either of the above groups are filtered out.
(3) For filtering out polymorphisms and artifacts that commonly occur in multiple control samples, ITDs sharing the same ITDBPPs as the set of control samples are removed.
RESULTS

Analysis of synthetic data
Using synthetic data, we evaluated the sensitivity and precision of Genomon ITDetector by altering three parameters: allele frequency, read depth and ITD length. See Supplementary Materials for detailed simulation settings. Here, we only counted ITDs identified as grade A. As shown in Figure 1c , the sensitivity of the method was improved by increasing the read depth and allele frequency. However, even with sufficient read depths and allele frequencies, the sensitivity did not reach 100%, probably because of the difficulty of identifying ITDs located in repeat regions ( Supplementary Fig. S4 ). Despite this minor limitation, Genomon ITDetector achieved sufficiently high sensitivity for practical use. For example, as described in Figure 1c , 490% sensitivity was obtained in the detection of ITDs spanning 20-60 bp at an allele frequency of 30% (which is the minimum condition for acceptable samples in the TCGA project, http:// cancergenome.nih.gov/cancersselected/biospeccriteria) and read depths of 100 [close to the mean and median of the exome sequencing data used in the Cancer Genome Atlas (TCGA) AML project (Ley et al., 2013) ]. For ITDs spanning 470 bp, sensitivity was significantly increased by adding ITDs identified as grades B and C ( Supplementary Fig. S5 and Table S1 ). Furthermore, the sensitivity decreased as the read length decreased (see Supplementary Materials).
Analysis of TCGA AML data
We used Genomon ITDetector to analyze exome sequencing data from 94 paired AML samples (Ley et al., 2013, see Supplementary Materials for the detailed procedure). Please refer to Supplementary Figure S6 for each of the filtering steps used to reduce putative false positives. The computational resources required were 1 CPU core [Intel Xeon X5675 (3.06 GHz)], 5.0-7.7 GB, for each process. The average calculation time was 4.2 h, with a maximum of 22 h and a minimum of 1.5 h. In total, we identified 719 ITDs in coding regions, of which 45 and 20 were classified as grades A and B, respectively. ITDs involving FLT3 were identified in 20 samples (grade A: 16, grade B: 1, grade C: 6; see Supplementary Fig. S8 ). Furthermore, ITDs affecting cancer genes (registered in the Cancer Gene Census, http://cancer.sanger.ac.uk/cancergenome/projects/census/), such as CEBPA (Lin et al., 2005) , KIT (Corbacioglu et al., 2006) and WT1, were identified as grade A. These results showed that Genomon ITDetector is able to detect a number of ITDs in putative cancer driver genes with high sensitivity (Supplementary Table S2 ).
Comparison with Pindel
Most existing methods focus only on SVs of at least several hundred base pairs in size. Although Pindel (Ye et al., 2009) can detect short (10-200 bp) tandem duplications, it is not specifically designed for detecting 'somatic' changes.
To evaluate the performance of Genomon ITDetector, we devised a simple framework for the detection of somatic ITDs using Pindel (s-Pindel) and compared it with Genomon ITDetector. These results suggested that although s-Pindel detected a similar number of FLT3-ITDs to Genomon ITDetector, it produced more putative false positives. Therefore, a simple extension of Pindel is not sufficient for accurate genome-wide screening of somatic ITDs, and Genomon ITDetector is a significant advancement. However, there is room for further improvement in Genomon ITDetector, as several probable ITDs were identified only by s-Pindel. The details of this comparison are shown in Supplementary Material S6. Integration of the merits of Pindel and Genomon ITDetector to produce a more sensitive and accurate software will be investigated in the future.
DISCUSSION
The effectiveness of Genomon ITDetector for detecting somatic ITDs was demonstrated using both synthetic and real data. Still, there are several remaining issues. First, the current approach cannot detect ITDs with more than two duplicates. One possible solution would be to check whether the OIN in the assembled contig sequence is double, triple or greater of the PDNs. Second, the proposed approach is for somatic ITD detection only, not germ line detection. For the detection of germ line ITDs, alignment artifacts and germ line ITDs must be effectively distinguished. For this filtering, use of multiple non-matched control samples may provide a solution; however, the data cannot be used directly in our current method, and this problem requires further investigation.
